Shi LH - Search Results

1

Preparation and antitumor activity of a tamibarotene-furoxan derivative.

Wang XJ, Duan Y, Li ZT, Feng JH, Pan XP, Zhang XR, Shi LH, Zhang T. Wang XJ, et al. Among authors: shi lh. Asian Pac J Cancer Prev. 2014;15(15):6343-7. doi: 10.7314/apjcp.2014.15.15.6343. Asian Pac J Cancer Prev. 2014. PMID: 25124622 Free article.

2

Gab2 expression in glioma and its implications for tumor invasion.

Shi L, Sun X, Zhang J, Zhao C, Li H, Liu Z, Fang C, Wang X, Zhao C, Zhang X, Zhou F, Lu S, Luo R, Zhang B. Shi L, et al. Acta Oncol. 2013 Nov;52(8):1739-50. doi: 10.3109/0284186X.2012.750032. Epub 2012 Dec 11. Acta Oncol. 2013. PMID: 23231021

3

A new cell counting method to evaluate anti-tumor compound activity.

Wang XJ, Zhang XR, Zhang L, Li QH, Wang L, Shi LH, Fang CY. Wang XJ, et al. Among authors: shi lh. Asian Pac J Cancer Prev. 2014;15(8):3397-401. doi: 10.7314/apjcp.2014.15.8.3397. Asian Pac J Cancer Prev. 2014. PMID: 24870728 Free article.

4

Autocrine IL-8 promotes F-actin polymerization and mediate mesenchymal transition via ELMO1-NF-κB-Snail signaling in glioma.

Zhang B, Shi L, Lu S, Sun X, Liu Y, Li H, Wang X, Zhao C, Zhang H, Wang Y. Zhang B, et al. Cancer Biol Ther. 2015;16(6):898-911. doi: 10.1080/15384047.2015.1028702. Epub 2015 Apr 14. Cancer Biol Ther. 2015. PMID: 25870011 Free PMC article.

5

Inhibition of leucine aminopeptidase 3 suppresses invasion of ovarian cancer cells through down-regulation of fascin and MMP-2/9.

Wang X, Shi L, Deng Y, Qu M, Mao S, Xu L, Xu W, Fang C. Wang X, et al. Eur J Pharmacol. 2015 Dec 5;768:116-22. doi: 10.1016/j.ejphar.2015.10.039. Epub 2015 Oct 23. Eur J Pharmacol. 2015. PMID: 26526349

6

Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition.

Sun ZP, Zhang J, Shi LH, Zhang XR, Duan Y, Xu WF, Dai G, Wang XJ. Sun ZP, et al. Among authors: shi lh. Biomed Pharmacother. 2015 Dec;76:65-72. doi: 10.1016/j.biopha.2015.10.023. Epub 2015 Nov 10. Biomed Pharmacother. 2015. PMID: 26653552

7

CC chemokine ligand 18(CCL18) promotes migration and invasion of lung cancer cells by binding to Nir1 through Nir1-ELMO1/DOC180 signaling pathway.

Shi L, Zhang B, Sun X, Zhang X, Lv S, Li H, Wang X, Zhao C, Zhang H, Xie X, Wang Y, Zhang P. Shi L, et al. Mol Carcinog. 2016 Dec;55(12):2051-2062. doi: 10.1002/mc.22450. Epub 2016 Jan 12. Mol Carcinog. 2016. PMID: 26756176

8

Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.

Cheng CC, Shi LH, Wang XJ, Wang SX, Wan XQ, Liu SR, Wang YF, Lu Z, Wang LH, Ding Y. Cheng CC, et al. Among authors: shi lh. Int J Oncol. 2018 Jul;53(1):339-348. doi: 10.3892/ijo.2018.4399. Epub 2018 May 8. Int J Oncol. 2018. PMID: 29750424

9

Knockdown of ARK5 expression suppresses invasion of ovarian cancer cells.

Wang S, Li S, Wang H, Li W, Gao Y, Wang X, Fang C, Zhang B, Sun X, Li R, Shi W, Chen M, Shi L. Wang S, et al. Mol Med Rep. 2019 Apr;19(4):2927-2934. doi: 10.3892/mmr.2019.9901. Epub 2019 Jan 28. Mol Med Rep. 2019. PMID: 30720082

10

Overexpression of Stat3 increases circulating cfDNA in breast cancer.

Wang YF, Wang XJ, Lu Z, Liu SR, Jiang Y, Wan XQ, Cheng CC, Shi LH, Wang LH, Ding Y. Wang YF, et al. Among authors: shi lh. Breast Cancer Res Treat. 2021 May;187(1):69-80. doi: 10.1007/s10549-021-06142-6. Epub 2021 Feb 25. Breast Cancer Res Treat. 2021. PMID: 33630196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page